Calian Group (TSE:CGY – Get Free Report) had its price target raised by CIBC World Markets from C$65.00 to C$76.00 in a research report issued to clients and investors on Friday,BayStreet.CA reports. CIBC World Markets’ target price would indicate a potential upside of 7.31% from the stock’s previous close.
Several other research firms have also weighed in on CGY. Desjardins upped their price objective on shares of Calian Group from C$59.00 to C$66.00 and gave the company a “buy” rating in a research note on Thursday, November 27th. Royal Bank Of Canada upped their price target on shares of Calian Group from C$58.00 to C$66.00 and gave the stock an “outperform” rating in a research note on Thursday, November 27th. Canadian Imperial Bank of Commerce increased their price objective on Calian Group from C$62.00 to C$65.00 in a report on Wednesday, January 14th. Canaccord Genuity Group lifted their price objective on Calian Group from C$60.00 to C$63.00 and gave the company a “buy” rating in a research report on Thursday, November 27th. Finally, Ventum Financial boosted their target price on Calian Group from C$62.00 to C$72.00 and gave the company a “buy” rating in a research note on Tuesday, January 27th. Six investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of C$73.43.
Get Our Latest Stock Report on CGY
Calian Group Stock Up 7.1%
Calian Group (TSE:CGY – Get Free Report) last released its earnings results on Thursday, February 12th. The company reported C$1.03 earnings per share for the quarter. The company had revenue of C$208.00 million for the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%. On average, analysts anticipate that Calian Group will post 4.9475219 earnings per share for the current year.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Recommended Stories
- Five stocks we like better than Calian Group
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
